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BACKGROUND:  We  describe  an  evaluation  of the  effects  of  partial  Roux-en-Y  gastric  bypass  (RYGB) rever-
sal on postprandial  hyperinsulinaemic  hypoglycaemia,  insulin  and  GLP-1  levels.
CASE  SUMMARY:  A 37  year  old  man  was  admitted  with  neuroglycopenia  (plasma–glucose  1.6 mmol/l)  18
months  after  RYGB,  with  normal  72 h  fasting  test  and  abdominal  CT. Despite  dietary  modiﬁcations  and
medical  treatment,  the hypoglycaemic  episodes  escalated  in  frequency.  Feeding  by a  gastrostomy  tube
positioned  in the  gastric  remnant  did  not  prevent  severe  episodes  of  hypoglycaemia.  A modiﬁed  reversal
of the  RYGB  was  performed.  Mixed  meal  tests  were  done  perorally  (PO),  through  the gastrostomy  tube
1 (GT1),  4 weeks  (GT2)  after  placement  and  4  weeks  after  reversal  (POr),  with  assessment  of  glucose,
insulin  and  GLP-1  levels.
RESULTS:  Plasma–glucose  increased  to a maximum  of  9.6,  5.4,  6.5 and  5.8 mmol/l  at the  PO,  GT1,  GT2  and
POr  tests  respectively.  The  corresponding  insulin  levels  were  2939,  731,  725  and  463 pmol/l.  A  decrease  of
plasma–glucose  followed:  2.2,  3.0,  3.9 and  2.9 mmol/l  respectively  and  insulin  levels  were  suppressed  atase report
150 min:  45,  22, 21  and  14  pmol/l,  respectively.  GLP-1  levels  increased  in  the PO  test  (60  min:  122  pmol/l,
21  fold  of basal),  but  was  attenuated  in the  two  latter  tests  (12–23  pmol/l  at 60 min).
CONCLUSIONS:  Reduction  of plasma–glucose,  insulin  and  GLP-1  excursions  and  symptoms  were  seen  after
gastric  tube  placement  and partial  RYGB  reversal.  This attenuation  of  GLP-1  response  to  feeding  could
reﬂect  an  adaptation  to nutrients.
© 2016  Published  by Elsevier  Ltd.  on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
he  CCunder  t
. Background
Roux-en-Y gastric bypass (RYGB) is widely used to treat mor-
id obesity (Fig. 1a). Postprandial hyperinsulinemic hypoglycaemia
PHH) can be a complication after RYGB and potentially difﬁcult to
reat [1,2]. The mechanisms for PHH are not fully understood, but
xaggerated incretin responses play a role [3,4]. A small subgroup
f patients does not respond to dietary changes and medical ther-
py. For these patients, surgical reversal or pancreatectomy have
een proposed although the optimal surgical treatment has not
een deﬁned [5,6].We describe a patient with severe PHH unresponsive to non-
urgical treatment. A novel surgical approach of partial reversal of
he RYGB was  successfully used. Here we describe the pre- and
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postoperative physiological responses demonstrating the resolu-
tion of PHH.
2. Patient and methods
A 37-year-old man  (weight 183 kg, height 185 cm,  BMI
53.5 kg/m2) with known bradycardia, asthma and gout, but no
diabetes, had a laparoscopic RYGB with a 150 cm (antecolic) ali-
mentary and a 50 cm bilio–pancreatic limb (Fig. 1a). One year after
surgery he had lost 88 kg (48% total weight loss) and his BMI  was
reduced to 27.7 kg/m2.
Eighteen months after surgery the patient was admitted to hos-
pital with neuroglycopenic symptoms relieved by consumption of
carbohydrates and plasma–glucose of 1.6 mmol/l. He used stan-
dard nutritional supplements, but no drugs and rarely alcohol.
Serum–cortisol, thyroid function tests, cerebral- and abdominal
CT scans, cardiac evaluation and plasma–glucose after a 72 h fast
were normal. Despite dietary modiﬁcations and self-monitoring
of blood–glucose the hypoglycaemic episodes and hospital admis-
sions increased in frequency. Acarbose was attempted but not
is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 1. Panel a depicts the entero–entero anastomosis (OEE) and the gastro–jejunostomy after Roux-en-Y gastric bypass. Panel b demonstrates the division of the alimentary
limb  6 cm below the gastro–jejunostomy and the anastomosis of the proximal part of the alimentary limb to the gastric remnant. A new entero–entero anastomosis is made
between the former alimentary and bilio–pancreatic limb following transection of the original entero–entero anastomosis at the bilio–pancreatic limb side. A is previously
p rweg
f reativ
r
t
6
V
c
l
u
i
r
t
t
t
w
t
f
v
p
4
i
t
e
p
p
a
r
f
i
g
h
D
fublished in D. Hofsø et al.: Follow-up after bariatric surgery, in the Journal of the No
or  our paper by K. Toverud, CMI. The images are not covered by the terms of the C
ights  holder (K. Toverud, CMI).
olerated due to gastrointestinal side effects. Diazoxide up to
00 mg  daily had little effect and was discontinued due to dyspnea.
erapamil was not considered as the patient had bradycardia. Sub-
utaneous injection of octreotide (50 mcg  3 times daily) resulted in
ess severe PHH for some weeks, but the effect gradually atten-
ated and his alanine transaminase and aspartate transaminase
ncreased.
Severe symptomatic hypoglycaemia occurred on a daily basis
esulting in hospital admission for glucose infusions. In an attempt
o alleviate the symptoms, feeding through a gastrostomy tube into
he remnant stomach was  started. The laparascopic positioning of
he gastrostomy tube was complicated by subileus and the patient
as reoperated. To evaluate if feeding through the gastrostomy
ube would decrease the PHH a standard mixed meal test was  per-
ormed orally before the gastrostomy tube placement (PO), and
ia the tube at 1 week (GT1) and 4 weeks (GT2) after the tube
lacement. The test meal; 200 ml  of Fresubin 2 kcalTM (400 kcal,
5 g carbohydrates, 20 g protein and 15.6 g fat) was  ingested or
nfused through the gastric tube over 12 min. During the tests,
he Edinburgh symptom scale for hypoglycaemia [8] was  used to
valuate hypoglycaemic symptoms every 15 min, in parallel with
ulse and BP measurements. Plasma–glucose, serum–insulin and
lasma–GLP-1 were measured every 15 min  during the ﬁrst hour,
nd then every 30 min  until the end of the test.
Four weeks after the last test the patient developed recur-
ent abdominal pain, especially after ingestion of oral ﬁber-rich
oods, and became dependent on continuous parenteral glucose
nfusions to prevent hypoglycemia. He developed signs of hypo-
lycaemia unawareness. Reduced oral feeding did not prevent the
ypoglycaemia, in spite of gradually increased nutrition (250 ml  × 3
TMiaben ) through the gastric tube.
RYGB reversal: Due to prolonged hospitalization, the need
or continuous glucose infusions and the development ofian Medical Association, 2011, by permission from K. Toverud, CMI. B was produced
e Commons licence of this publication. For permission to reuse, please contact the
hypoglycaemic unawareness surgery was considered. The patient
was ﬁnally offered a modiﬁed reversal of the RYGB (Fig. 1b).
During laparoscopy the gastrostomy tube was removed
and the alimentary limb was transected 6 cm below the
gastro–jejunostomy (Fig. 1b). A side-to-side anastomosis was cre-
ated between the highest part of the remnant stomach on the minor
side and the small bowel 6 cm below the original RYGB pouch.
The bilio–pancreatic limb was divided at the entero–entero anas-
tomosis and a new side-to-side entero–entero anastomosis was
created between the previously divided alimentary limb and the
bilio–pancreatic limb.
The same mixed meal was  given orally 4 weeks after the RYGB
reversal (POr).
Biochemical analysis: Plasma–glucose was analyzed every 5 min
by a glucose oxidase method (YSI Inc., Yellow Springs, Ohio, USA.).
Serum–insulin was  analyzed at the Hormone Laboratory (ECLIA,
Roche diagnostic Inc.). Plasma–GLP-1 samples were centrifuged
and frozen at −80◦ and analyzed later in one run by an EMD  Milli-
pore ELISA kit (CV 8%).
The present case report is compliant with the CARE Guidelines
[7].
3. Results
During the mixed meal testing pre-intervention, Serum–insulin
levels increased rapidly during the ﬁrst 30 min  in parallel with glu-
cose levels, and were later suppressed. Plasma–glucose decreased
from 30 to 90 min. Plasma–GLP-1 levels demonstrated exaggerated
responses during the ﬁrst two  tests (PO, GT1), but was  attenuated
at both the GT2 and the POr tests (Fig. 2a–c).Symptoms and signs during both the PO and GT1 tests included
palpitations, abdominal pain, nausea, sleepiness and redness. These
symptoms were attenuated after gastric tube adaptation (GT2).
Postoperatively (POr), the patient experienced neither symptoms
CASE  REPORT  –  O
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Fig. 2. Panel a–c respectively: Plasma–glucose, serum–insulin and plasma–GLP-1
levels during tests (peroral ), gastric tube unadapted (GT1 +), gastric tube adapted
(GT2 ×), peroral after reversion (POr ). # indicates the point where the PO test was
s
g
o
h
e
a
8
g
5
p
t
u
a
planned and performed the tests, TM and JAK planned and per-topped due to a serious episode of hypoglycaemia (2,0 mmol/l), necessitating iv.
lucose injection.
f hypoglycaemia, nor episodes of abdominal pain. The patient
ad one episode of constipation successfully corrected by a barium
nema.
The patient was reviewed two months after the RYGB reversal
nd reported no hypoglycaemic symptoms. His body weight was
7.3 kg. Three months after the partial reversal of RYGB, continuous
lucose monitoring demonstrated plasma–glucose levels around
 mmol/l, and no report of hypoglycaemic symptoms in spite of
rovocations with high glycaemic meals. At 10 months post opera-
ively he weighed 94 kg, reported some dyspepsia, but had a normal
pper endoscopy and infrequent low blood glucose levels (lowest
t 2.7 mmol/l), but no hypoglycaemic symptoms.PEN  ACCESS
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4. Discussion
In our patient the symptoms of PHH resolved after partial rever-
sal of the RYGB and he returned to work 6 weeks after surgery. We
found a reduction in hypoglycaemia and symptoms three weeks
after gastric tube feeding was started, with further improvement
after RYGB reversal. The attenuation of plasma–GLP-1 and insulin
responses were associated with improved plasma–glucose and
symptoms during to the two  latter meal tests (GT2 and POr).
The exaggerated plasma–GLP-1 response at the GT1 visit, which
involved feeding through the gastrostomy tube, suggests that the
duodenum and jejunum in the bilio–pancreatic limb had an exac-
erbated response to the mixed meal. The subsequent attenuated
GLP-1 response during GT2 and POr tests, suggests small bowel
adaptation, resulting in a diminutive response triggered by the
mixed meals.
The optimal surgical approach to patients with post-RYGB hypo-
glycaemia not responding to diet and/or pharmacotherapy has
not been deﬁned [6]. A gastrostomy tube has been used by some
authors to test the potential effects of RYGB reversal. Our ﬁnd-
ings suggest time to pass for an enteral adaptation to nutrition
by the gastric tube, prior to testing the effect of tube feeding on
plasma–glucose levels and symptoms of hypoglycaemia.
Pancreatic resection and reversal have both been used in an
attempt to relieve PHH [6]. To prevent weight regain a sleeve gas-
trectomy has been performed together with the RYGB reversal [5].
We describe a technically easier reversal while potentially retain-
ing some component of nutritional restriction as the original gastric
pouch is preserved. This may  reduce the risk of weight regain. This
approach has to our knowledge, not previously been described in
the context of surgical treatment to PHH after RYGB. Our  short-
term ﬁndings indicate that the procedure alleviates the symptoms
of hypoglycaemia. Further study of long-term outcome is necessary
for evaluation of the clinical applicability of this technique of RYGB
reversal.
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